Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation

Lignende værker

• mTOR Inhibitors Control the Growth of EGFR Mutant Lung Cancer Even after Acquiring Resistance by HGF
  af: Ishikawa, Daisuke, et al.
  Udgivet: (2013)
• Ability of the Met Kinase Inhibitor Crizotinib and New Generation EGFR Inhibitors to Overcome Resistance to EGFR Inhibitors
  af: Nanjo, Shigeki, et al.
  Udgivet: (2013)
• High efficacy of third generation EGFR inhibitor AZD9291 in a leptomeningeal carcinomatosis model with EGFR-mutant lung cancer cells
  af: Nanjo, Shigeki, et al.
  Udgivet: (2015)
• Receptor ligand-triggered resistance to alectinib and its circumvention by Hsp90 inhibition in EML4-ALK lung cancer cells
  af: Tanimoto, Azusa, et al.
  Udgivet: (2014)
• Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer
  af: Zhao, Lu, et al.
  Udgivet: (2013)